Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) released its earnings results on Friday. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.09, Zacks reports. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%.The firm had revenue of $966.53 million during the quarter, compared to analyst estimates of $848.42 million.

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 1.0%

Shares of SGIOY traded up $0.10 during midday trading on Friday, hitting $10.22. The company had a trading volume of 50,568 shares, compared to its average volume of 143,744. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $6.74 and a 1 year high of $10.30. The firm has a market capitalization of $17.39 billion, a P/E ratio of 15.97, a P/E/G ratio of 2.10 and a beta of 0.19. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.74 and a current ratio of 6.44. The company’s 50-day simple moving average is $9.01 and its 200-day simple moving average is $8.72.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.